Product Information

IBUPROFEN 800 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0585 per EA under NDC 64380080706. Its NADAC has been published 416 times since Sep 5, 2018.

FDA first approved this application on Feb 5, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 800 MG TABLET

Ibuprofen
$0.0585per EA

Strength

800 mg/1

NDC

64380080706

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078329

FDA Approved

2/5/2009

TE Code

AB

On Market Since

8/24/2018

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 800 MG TABLET has been published 416 times since Sep 5, 2018, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0585 per EA
All-time high$0.0933 (Mar 11, 2020)
All-time low$0.0511 (Nov 20, 2024)
52-week high$0.0601
52-week low$0.0549
Median price$0.0683
Average price$0.0699
Largest weekly change-20.3% (Apr 17, 2024)
Weeks tracked416
Tracking sinceSep 5, 2018

Price History

1W

+5.1%

1M

+5.1%

3M

+3.1%

6M

+6.5%

1Y

-2.7%

3Y

-9.8%

5Y

-23.5%

All

-5.4%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of IBUPROFEN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Strides Pharma Inc., is $0.0585 per EA (NDC 64380080706), effective Aug 19, 2026.

How has the price of IBUPROFEN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has declined 5.4%. It has been tracked across 416 weekly CMS publications since Sep 5, 2018.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?

Since Sep 5, 2018, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0511 (Nov 20, 2024) to a high of $0.0933 (Mar 11, 2020), with a median of $0.0683 per EA.

Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?

Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 800 MG TABLET, is $0.0567 per EA — about 3% below IBUPROFEN 800 MG TABLET.

Who manufactures IBUPROFEN 800 MG TABLET?

IBUPROFEN 800 MG TABLET (NDC 64380080706) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.